Wales Commercial Research Delivery funding call now open

Health and Care Research Wales is opening a call to submit requests for funding required to support the delivery of commercial pharmaceutical interventional research, where the cost will be incurred from the 1 April 2025.

The purpose of this Voluntary Scheme for Branded Medicines Pricing and Access (VPAG) funding is to pump prime clinical trial capability, by increasing workforce capacity and infrastructure as well providing agility relevant to the set up and delivery of commercial clinical research. This investment must accelerate the delivery of commercial pharmaceutical interventional research for the measurable benefit of health and wealth in Wales. It is expected that applicants make a strong case to demonstrate that the investment secured will be sustainable through income generation in a defined timescale

The call is open to stakeholders from all disease specialties, specialist services and the clinical research infrastructure within the NHS and Higher Education Institutions.

For more information and to submit a funding request view the guidance and application form. Applicants should use the VPAG finance plan template alongside the application form to complete their submission.

Deadline to apply: 23:59 on 7 February 2025